IL6 and familial dilated cardiomyopathy: In contrast, a recent study indicated that IL-6 value was not significantly higher in idiopathic DCM patients with poor clinical outcomes (died or underwent transplantation) in comparison to those with better outcomes who were also less likely to be in NYHA class III and to have lower LVEF.13